Clinical Trial Update: Dose-response of Cannabis and Driving [Phase 2]

View source ↗

Summary

Phase 2 trial investigating dose-response of cannabis on driving impairment and cognitive effects; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Driving Impairment

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Driving Impaired, Cognitive Impairment | Phase 2 | Status: COMPLETED